This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Berkelhammer, C. Articles by Sitrin, M. D. Search for Related Content PubMed PubMed Citation Articles by Berkelhammer, C. Articles by Sitrin, M. D. Social Bookmarking                         What's this?

Inorganic Phosphorus Reduces Hypercalciuria During Total Parenteral Nutrition By Enhancing Renal Tubular Calcium Absorption

Department of Medicine, Section of Gastroenterology and Clinical Nutrition Research Unit, The University of Chicago, Christ Hospital, Oak Lawn, IL 60433

Richard J. Wood, PHD

Department of Medicine, Section of Gastroenterology and Clinical Nutrition Research Unit, The University of Chicago, Mineral Bioavailability Laboratory, USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111

Michael D. Sitrin, MD

Department of Medicine, Section of Gastroenterology and Clinical Nutrition Research Unit, The University of Chicago

Background: Increasing the inorganic phosphorus content of total parenteral nutrition (TPN) formulas has been shown to decrease TPN-induced hypercalciuria in experimental animals and humans. The mechanism of this effect, however, has been uncertain. Methods: By using a randomized cross-over design, seven patients on cyclic TPN were given otherwise identical formulas providing either 15 or 45 mmol/d of inorganic phosphorus. Urinary calcium excretion, serum ultrafilterable calcium, filtered calcium load, fractional calcium excretion, urinary cyclic adenosine 5'-monophosphate (cAMP), and serum levels of ionized calcium, parathyroid hormone (PTH), and vitamin D metabolites were determined at the end of each study period. Results: Urinary calcium excretion was significantly lower when the patients received the higher inorganic phosphorus formula. Increasing the inorganic phosphorus in the TPN formula did not change ultrafilterable calcium or filtered calcium load, but significantly reduced fractional calcium excretion. No differences in serum levels of ionized calcium, PTH, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, or urinary cAMP were observed between treatments. Conclusions: These results demonstrate that increasing the inorganic phosphorus content of the TPN formula decreases urinary calcium excretion by increasing renal tubular calcium resorption. This effect is not due to alterations in the PTH-1,25-dihydroxyvitamin D axis, but likely reflects a direct action of inorganic phosphorus on the renal tubules. (Journal of Parenteral and Enteral Nutrition 22:142-146, 1998)

Journal of Parenteral and Enteral Nutrition, Vol. 22, No. 3, 142-146 (1998)
DOI: 10.1177/0148607198022003142


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. E. Marks and C. M. Crill Calcium and Phosphorous in Pediatric Parenteral Nutrition Journal of Pharmacy Practice, December 1, 2004; 17(6): 432 - 446. [Abstract] [PDF]